The Punjab government has approved the use of Actemra, a life-saving drug, for treating critically ill Covid-19 patients in the wake of a sudden rise in the death rate reported by state-run hospitals across the province.
The 400mg injectable drug — an interleukin-6 inhibitor which goes by the generic name of tocilizumab — will be prescribed to patients who develop lung complications and an abnormal level of IL-6 in the blood. The IL-6 is an endogenous chemical which causes inflammation.
Read full story here.
